According to recent medical studies, the diabetes drug Avandia can greatly increase a patient’s risk of a heart attack. Avandia is prescribed to treat type ll diabetes and is taken by millions of diabetics. However, some studies have shown that Avandia can increase the risk of heart attacks by 43%, and can increase the chance of cardiac-related death by 64%.
In a recent meeting expert panelists at the FDA voted 21 to 4 that Avandia is more likelly to cause heart attacks than it’s competitor drug Actos. Despite this, Avandia remains on the market.